Ropes & Gray counseled Arcadia Consumer Healthcare, a portfolio company of Avista Capital Partners, in its purchase of the U.S. rights to the Kaopectate® brand from Sanofi. The transaction was announced on March 20. Terms of the transaction weren’t disclosed. The press release is here.
Arcadia Consumer Healthcare, Inc., formerly Kramer Laboratories, Inc., is a recognized leader in the consumer healthcare market for over-the-counter medicines. For over 35 years, the company has delivered innovative healthcare products to help consumers self-treat their everyday problems. Avista Capital Partners is a leading middle-market healthcare-focused private equity firm.
The Ropes & Gray team that advised Arcadia Consumer Healthcare was led by private equity partners David Blittner and Bob Rivollier, and included Arkadiusz Maczka (all of New York).
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.